Foslevodopa
Foslevodopa Uses, Dosage, Side Effects, Food Interaction and all others data.
Foslevodopa is under investigation in clinical trial NCT04750226 (Study to Assess Adverse Events and Change in Disease Activity of 24-hour Continuous Subcutaneous Infusion of ABBV-951 in Adult Participants With Advanced Parkinson's Disease).
| Trade Name | Foslevodopa |
| Generic | Foslevodopa |
| Foslevodopa Other Names | 3-hydroxy-O-phosphono-L-tyrosine, Foslevodopa, Levodopa-4'-monophosphate |
| Type | |
| Formula | C9H12NO7P |
| Weight | Average: 277.169 Monoisotopic: 277.035138728 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Foslevodopa
